人工智能在消化科实践中的改良德尔菲共识
美国胃肠病学会组建多学科工作组,通过改良德尔菲法就人工智能在消化内镜、肝病、炎症性肠病等领域的应用形成共识。43条声明中40条首轮达成共识,其余3条第二轮达成,强调AI应增强而非替代临床专业能力,并关注验证、公平性与培训。
要点
- 计算机辅助检测在对照研究中提高腺瘤检出率并降低漏诊率,但真实世界影响不一。
- 推荐对AI工具进行充分验证,并使用异质性数据集减少偏倚。
- 培训应包含结构化AI课程,同时保持独立操作能力以避免技能退化。
核心结论
- AI可增强而非替代临床专业能力,同时促进安全性、透明度、互操作性和公平性。
研究设计与样本
- 美国胃肠病学会组建32名专家和12个行业伙伴的工作组,围绕5个关键领域进行文献回顾。
- 采用改良德尔菲法,以5点李克特量表评分,共识阈值设为≥70%合并同意率。
主要发现
- 43条声明中40条(93%)在第一轮达成共识,剩余3条在第二轮达成共识。
- 证据支持计算机辅助检测在对照研究中改善腺瘤检出率和漏诊率,但真实世界影响不一且长期结局证据不足。
- 内镜之外,环境AI记录、自然语言处理编码、工作流优化和预授权支持显示出潜力。
- 在炎症性肠病和肝病中,AI可能帮助提高诊断准确性、预测疾病进展风险和指导治疗。
关键数值与推荐
- 共识阈值设为≥70%合并同意率。
- 证据支持计算机辅助检测改善腺瘤检出率和漏诊率(对照研究)。
临床怎么用
- 推荐对AI工具进行充分验证并使用异质性数据集减少偏倚。
- 培训建议采用结构化AI课程,同时保持独立操作能力以避免技能退化。
- 公平、治理和报销声明呼吁数据保管链保护、专业学会监督及奖励质量和降低成本的支付模式。
局限性
- 长期结局证据不足,如间期结肠癌发生率。
- 计算机辅助检测的真实世界影响不一。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The American College of Gastroenterology assembled a multidisciplinary task force to evaluate the current state and future direction of artificial intelligence (AI) in gastroenterology, hepatology, and endoscopy leading to the development of consensus-based recommendations for responsible AI integration in clinical practice. METHODS: A total of 32 subject-matter experts and 12 industry partners, representing diverse practice settings and expertise, conducted subgroup literature reviews across 5 key areas (endoscopy, practice management clinical applications, training and education, inflammatory bowel disease and liver disease, ethics and equity). Draft statements were developed and rated on a 5-point Likert scale using a modified Delphi process. A consensus was set at ≥70% combined agreement. Nonconsensus items were revised and revoted electronically. RESULTS: A total of 43 statements, 40 (93%) reached consensus in round 1 and the remaining 3 achieved consensus after round 2. Evidence supports computer-aided detection improving adenoma detection rate and miss rate in controlled studies, with mixed real-world impact and insufficient long-term outcomes (e.g., interval colon cancer rate). Recommendations emphasize thorough validation and reduction of bias by heterogeneous Data sets. Outside endoscopy, ambient AI scribes, natural language processing (NLP)-enabled coding, workflow optimization, and previous authorization support show potential. Training recommendations endorse a structured AI curriculum while preserving independent procedural competence to avoid deskilling. In inflammatory bowel disease and hepatology, AI could help improve diagnostic accuracy, help predict risk of disease progression, and help guide therapy. Equity, governance, and reimbursement statements call for chain-of-custody data protections, specialty-society oversight, and payment models that reward quality and cost reduction. DISCUSSION: This consensus outlines how AI can augment rather than replace clinical expertise while promoting safety, transparency, interoperability, and equity. Priorities include pragmatic and prospective trials, multi-institutional data-sharing consortia, bias mitigation, and workforce training to enable trustworthy and clinically impactful AI adoption in gastroenterology, liver, and endoscopy care.
引用
- Gross SA, Shaukat A, Afzali A, et al. Artificial Intelligence for Gastroenterology Practice: A Modified Delphi Consensus. Am J Gastroenterol. 2026. PMID: 41665234. doi:10.14309/ajg.0000000000003944
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。